Cargando...
Mineralocorticoid receptor antagonist use following heart failure hospitalization
AIMS: Patients hospitalized for heart failure (HF) are at increased risk for events post‐discharge. Mineralocorticoid receptor antagonists (MRAs) improve the clinical course of patients with HF with reduced ejection fraction. We assessed MRA use in high‐risk patients following an HF hospitalization...
Gardado en:
| Publicado en: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160481/ https://ncbi.nlm.nih.gov/pubmed/32035000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12635 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|